Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 71 resultados

VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado

BEAMER: BEhavioral and Adherence Model for improving quality health outcomes and cost Effectiveness of heal... MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage The main objective of the Project is to create BEAMER, a disease-agnostic behavioral and adherence model for improving quality, health outco...
2021-09-27 - 2026-08-31 | Financiado

RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado

PERSIST-SEQ: Building a reproducible single cell experimental workflow to capture tumour cell persistence MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage It is the ambition of PRESIST-SEQ to provide a new gold standard in single-cell experimental workflows the cancer research community by deve...
2021-06-28 - 2026-06-30 | Financiado

InnCoCells: Innovative high value cosmetic products from plants and plant cells MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-FNR-2020 The InnCoCells project will develop innovative and sustainable plant-based production processes for the commercial exploitation of scientifi...
2021-05-03 - 2025-09-30 | Financiado

SISAQOL-IMI: Establishing international standards in the analysis of patient reported outcomes and health related... MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Measuring and quantifying how a patient feels or functions during treatment is an important endpoint in cancer clinical trials. It is genera...
2020-11-09 - 2024-12-31 | Financiado

ReSolute: HIGH PERFORMING AND SAFE SOLVENT DERIVED FROM CELLULOSIC FEEDSTOCKS MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-BBI-JTI-2019 ReSolute Project aims to pave the way for the production, at full industrial scale, of novel, non-toxic and high performing solvent from woo...
2020-09-21 - 2024-12-31 | Financiado

CARE: Corona Accelerated R D in Europe MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in thi...
2020-08-07 - 2025-03-31 | Financiado

imSAVAR: Immune Safety Avatar nonclinical mimicking of the immune system effects of immunomodulatory therapi... MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy saf...
2019-11-18 - 2025-11-30 | Financiado

Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado

MELLODDY: MachinE Learning Ledger Orchestration for Drug DiscoverY MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage MELLODDY will demonstrate how the pharmaceutical industry can better leverage its data assets to virtualize the Drug Discovery (DD) process...
2019-05-22 - 2022-05-31 | Financiado

ConcePTION: Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and... MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about...
2019-05-06 - 2024-12-31 | Financiado

IMMUcan: Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage IMMUcan proposes an inclusive and integrated European immuno-oncology platform. IMMUcan will access high-quality human biological material...
2019-04-23 - 2025-08-31 | Financiado

MOBILISE-D: Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage Optimal treatment of the impaired mobility resulting from ageing and chronic disease is one of the 21st century's greatest challenges facing...
2019-03-22 - 2024-06-30 | Financiado

ESCulab: European Screening Centre Unique Library for Attractive Biology MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage By bridging an important gap between basic research and drug development, ESCulab will facilitate the translation of fundamental scientific...
2018-12-18 - 2023-11-30 | Financiado

TADFlife: Using the smart matrix approach to enhance TADF OLED efficiency and lifetime MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-MSCA-ITN-2018 The European Training Network TADFlife will train a cohort of young PhD scientists within a multidisciplinary research program conceived fro...
2018-08-21 - 2022-12-31 | Financiado

CHARMING: Chemical Engineering Immersive Learning MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-MSCA-ITN-2018 The chemical industry in Europe faces stiff competition as it fights to strengthen its position in the global market place. Europe’s greates...
2018-08-20 - 2022-10-31 | Financiado

ApPEARS: Appearance Printing European Advanced Research School MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-MSCA-ITN-2018 The international manufacturing industry is undergoing radical changes in the way items are digitally printed and fabricated. From the home...
2018-08-20 - 2023-11-30 | Financiado

PARADIGM: Patients Active in Research and Dialogues for an Improved Generation of Medicines Advancing meaning... MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engage...
2018-06-04 - 2020-11-30 | Financiado

eTRANSAFE: Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sh...
2017-09-12 - 2023-02-28 | Financiado